Response to pembrolizumab in patients with mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC). Association of adjuvant chemotherapy with improved overall survival for patients with ...

CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

March 11, 2010 —Systematic removal of pelvic as well as para-aortic lymph nodes may improve survival time vs pelvic lymphadenectomy alone in patients at medium to high risk for endometrial cancer ...

Please provide your email address to receive an email when new articles are posted on . Extended lymphadenectomy did not improve outcomes in localized muscle-invasive bladder cancer vs. standard ...

The role of lymphadenectomy has been studied in both the localized and advanced settings over the past few decades, with a strong suggestion of no therapeutic benefit for patients with cT1-2N0M0 and ...

November 25, 2008 — Systematic pelvic lymphadenectomy does not improve disease-free or overall survival in patients with early-stage endometrial cancer, according to a report by Italian researchers ...

To evaluate the therapeutic benefit of lymphadenectomy and adjuvant therapy, in particular chemotherapy, we retrospectively analysed survival rates and patterns of recurrence of endometrioid ...

Fluorescence-guided lymphadenectomy after neoadjuvant chemotherapy was linked to improved survival in gastric cancer. It was also significantly associated with more retrieved lymph nodes. The 3-year ...

The role of systematic aortic and pelvic lymphadenectomy (SAPL) at second-look surgery in early stage or optimally debulked advanced ovarian cancer is unclear and never addressed by randomised studies ...

Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer. The addition of retroperitoneal ...